By Lila Rouland | Published on December 9, 2025 | 3 min readAging is associated with an increased risk of cognitive decline and
Alzheimer’s-related dementia. These disorders often begin with subtle
impairments in cognitive functions long before clinical symptoms emerge.
Early
intervention to slow this progression represents a major public health
challenge.
Cocoa flavanols, particularly
(-)-epicatechin, are antioxidant and
anti-inflammatory compounds believed to exert neuroprotective effects. Some
epidemiological studies have reported an association between cocoa consumption
and better cognitive performance. However,
results from randomized clinical
trials (RCTs) have been
inconsistent, with limited long-term data and
insufficiently detailed neuropsychological assessments.
What are the cognitive effects after two years of supplementation?
This investigation is part of the large COSMOS trial (21,442 participants),
which included a clinic subcohort of
573 volunteers who underwent
in-person
neuropsychological testing at baseline and again after two years.
Participants (mean age
69.6 years) were randomly assigned to receive either
cocoa extract or a placebo in a double-blind design. Cognitive testing assessed
global cognition (a composite score based on 11 tasks),
episodic memory, and
executive function/attention.
After two
years:
- No significant improvement was observed in the
cocoa group compared with placebo, whether for global cognition (mean
difference: -0.01 SD; 95% CI: -0.08 to 0.05), episodic memory (-0.01; CI:
-0.13 to 0.10), or executive function (0.003; CI: -0.07 to 0.08).
- Both groups showed slight score increases, likely
due to practice effects from repeated testing.
- Subgroup analyses suggested a potential benefit
in participants with low baseline diet quality, who showed trends toward
better global cognition and executive function.
Adherence to the intervention was high (>90% in both groups). No
significant interactions were found by age, sex, medical history, or flavanol
intake.
Does cocoa supplementation have clinical potential?
Cocoa, rich in flavanols and theobromine, exhibits vasodilatory,
antioxidant, and anti-inflammatory properties. Theoretically, it may promote
neurogenesis and cerebral perfusion, helping preserve cognitive function.
However, this rigorous two-year study does not provide evidence of an overall
cognitive benefit in healthy older adults.
Limitations include
low ethnic diversity, a
follow-up period too short to
detect early effects, and a lack of correction for multiple secondary analyses.
The dose used (500 mg/day) may also have been
insufficient for certain at-risk
individuals.
Nonetheless, the
positive signal observed among participants with poor diet
quality highlights an important avenue for future research.
Cognitive benefits
may vary according to baseline nutritional status, underscoring the need for
stratified approaches in upcoming trials.
Read next: Health Benefits in a Square: Chocolate to Better Combat Inflammation and Oxidative Stress
About the author – Lila RoulandDoctor of Oncology, specialized in Biotechnology and Management
With dual expertise in science and marketing, Lila brings her knowledge to the service of healthcare innovation. After five years in international academic research, she transitioned into medical and scientific communication within the pharmaceutical industry. Now working as a medical writer and content developer, she is committed to highlighting scientific knowledge and conveying it to healthcare professionals with clarity and relevance.